ACE-031 and Tamoxifen Interaction
ACE-031 and Tamoxifen have a potentially harmful interaction with 49% confidence. Both ACE-031 and Tamoxifen have anticoagulant or blood-thinning effects. Combined use significantly increases bleeding risk. Avoid unless under direct medical supervision. Both compounds affect the gonads and pituitary, so monitoring these systems is recommended.
Compound Profiles
ACE-031
Myostatin Inhibitor | Experimental Muscle Growth
ACE-031 acts as a ligand trap for members of the TGF-beta superfamily. By mimicking the extracellular domain of the ActRIIB receptor, it intercepts myostatin (GDF-8), activin A, activin B, and GDF-11 before they can bind cell-surface receptors and activate Smad2/3 signaling.
View full profileTamoxifen
Selective Estrogen Receptor Modulator | PCT & Breast Cancer Treatment
Tamoxifen competitively binds to estrogen receptors (primarily ERalpha) and exerts tissue-selective effects depending on the local coactivator and corepressor environment. In breast tissue and the hypothalamus, tamoxifen acts as an estrogen antagonist, blocking estradiol-mediated signaling.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take ACE-031 with Tamoxifen?
Combining ACE-031 with Tamoxifen is not recommended. Both ACE-031 and Tamoxifen have anticoagulant or blood-thinning effects. Combined use significantly increases bleeding risk. Avoid unless under direct medical supervision.
Is ACE-031 and Tamoxifen safe together?
This combination carries significant risk. Both ACE-031 and Tamoxifen have anticoagulant or blood-thinning effects. Combined use significantly increases bleeding risk. Avoid unless under direct medical supervision. Consult a healthcare professional before combining.
What are the interactions between ACE-031 and Tamoxifen?
Both ACE-031 and Tamoxifen have anticoagulant or blood-thinning effects. Combined use significantly increases bleeding risk. Avoid unless under direct medical supervision. This assessment has 49% confidence and is inferred from pharmacological mechanism analysis.
How should I time ACE-031 and Tamoxifen?
ACE-031 has a half-life of 12-15 days and Tamoxifen has a half-life of ~5-7 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.